He LR - Search Results

1

CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.

Li Y, He LR, Gao Y, Zhou NN, Liu Y, Zhou XK, Liu JF, Guan XY, Ma NF, Xie D. Li Y, et al. Among authors: he lr. Cell Death Dis. 2019 Feb 4;10(2):99. doi: 10.1038/s41419-019-1371-1. Cell Death Dis. 2019. PMID: 30718500 Free PMC article.

2

Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma.

He LR, Liu MZ, Li BK, Rao HL, Deng HX, Guan XY, Zeng YX, Xie D. He LR, et al. Cancer Sci. 2009 Sep;100(9):1591-6. doi: 10.1111/j.1349-7006.2009.01224.x. Epub 2009 May 18. Cancer Sci. 2009. PMID: 19552757 Free PMC article.

3

Clusterin as a predictor for chemoradiotherapy sensitivity and patient survival in esophageal squamous cell carcinoma.

He LR, Liu MZ, Li BK, Rao HL, Liao YJ, Zhang LJ, Guan XY, Zeng YX, Xie D. He LR, et al. Cancer Sci. 2009 Dec;100(12):2354-60. doi: 10.1111/j.1349-7006.2009.01349.x. Epub 2009 Sep 4. Cancer Sci. 2009. PMID: 19793084 Free PMC article.

4

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.

He LR, Liu MZ, Li BK, Jia WH, Zhang Y, Liao YJ, Chen YC, Zhang LJ, Guan XY, Zeng YX, Kung HF, Xie D. He LR, et al. Int J Cancer. 2010 Jul 1;127(1):138-47. doi: 10.1002/ijc.25031. Int J Cancer. 2010. PMID: 19904743

5

Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma.

He LR, Liu MZ, Li BK, Rao HL, Liao YJ, Guan XY, Zeng YX, Xie D. He LR, et al. BMC Cancer. 2009 Dec 22;9:461. doi: 10.1186/1471-2407-9-461. BMC Cancer. 2009. PMID: 20028503 Free PMC article.

6

Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma.

Yang GF, He WP, Cai MY, He LR, Luo JH, Deng HX, Guan XY, Zeng MS, Zeng YX, Xie D. Yang GF, et al. Among authors: he wp, he lr. BMC Cancer. 2010 Apr 8;10:133. doi: 10.1186/1471-2407-10-133. BMC Cancer. 2010. PMID: 20377880 Free PMC article.

7

PYRIN domain of NALP2 inhibits cell proliferation and tumor growth of human glioblastoma.

Wu GQ, Liao YJ, Qin ZQ, He LR, Chen YC, Zeng YX, Kung HF, Xie D. Wu GQ, et al. Among authors: he lr. Plasmid. 2010 Jul;64(1):41-50. doi: 10.1016/j.plasmid.2010.01.003. Epub 2010 Apr 11. Plasmid. 2010. PMID: 20388524

8

EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.

Rao ZY, Cai MY, Yang GF, He LR, Mai SJ, Hua WF, Liao YJ, Deng HX, Chen YC, Guan XY, Zeng YX, Kung HF, Xie D. Rao ZY, et al. Among authors: he lr. Carcinogenesis. 2010 Sep;31(9):1576-83. doi: 10.1093/carcin/bgq150. Epub 2010 Jul 28. Carcinogenesis. 2010. PMID: 20668008

9

Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients.

He LR, Zhao HY, Li BK, Liu YH, Liu MZ, Guan XY, Bian XW, Zeng YX, Xie D. He LR, et al. Int J Cancer. 2011 Jul 1;129(1):143-50. doi: 10.1002/ijc.25669. Int J Cancer. 2011. PMID: 20830705

10

Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma.

Zhao L, He LR, Zhang R, Cai MY, Liao YJ, Qian D, Xi M, Zeng YX, Xie D, Liu MZ. Zhao L, et al. Among authors: he lr. Med Oncol. 2012 Dec;29(4):2669-76. doi: 10.1007/s12032-011-0133-4. Epub 2011 Dec 14. Med Oncol. 2012. PMID: 22167391

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters